Related Experiment Videos
[Obstructive respiratory tract diseases--new standards in therapy].
1Medizinischen Klinik und Poliklinik, Berufsgenossenschaftlichen Krankenanstalten Bergmannsheil Bochum, Universitätsklinik.
Fortschritte Der Medizin
|November 20, 1992
Summary
Prophylactic treatment for obstructive airway diseases, including subacute bronchitis, involves inhaled corticosteroids and antibiotics. Advanced stages require bronchodilators and oral corticosteroids for effective management.
Area of Science:
- Pulmonology
- Pharmacology
- Internal Medicine
Context:
- Obstructive airway diseases (OADs) encompass conditions like subacute bronchitis and bronchial hypersensitivity.
- Early OAD symptoms necessitate prompt and effective therapeutic interventions.
Purpose:
- To present contemporary therapeutic strategies for managing OADs across different disease stages.
- To highlight the importance of prophylactic treatment in the early phases of OADs.
Summary:
- Early-stage OAD management focuses on prophylaxis with inhaled adrenocortical hormones (corticosteroids) and antibiotics.
- Manifest airway obstruction (Stage B) requires bronchodilators (e.g., beta-2 sympathomimetics), anticholinergics, and theophylline, with oral corticosteroids as a potential addition.
- Severe exacerbations (Stage C) necessitate intravenous corticosteroids, antibiotics, and a comprehensive range of bronchodilators.
- Functional analysis is crucial for preventing under- or overtreatment during OAD management.
Impact:
- Optimized therapeutic approaches can improve patient outcomes in obstructive airway diseases.
- Understanding staged treatment protocols ensures appropriate and effective patient care.
- This review provides a framework for clinicians managing diverse OAD presentations.